U.S. markets closed
  • S&P Futures

    3,841.50
    +32.25 (+0.85%)
     
  • Dow Futures

    31,141.00
    +229.00 (+0.74%)
     
  • Nasdaq Futures

    13,055.75
    +144.75 (+1.12%)
     
  • Russell 2000 Futures

    2,231.80
    +32.60 (+1.48%)
     
  • Crude Oil

    62.56
    +1.06 (+1.72%)
     
  • Gold

    1,745.30
    +16.50 (+0.95%)
     
  • Silver

    26.89
    +0.44 (+1.68%)
     
  • EUR/USD

    1.2086
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • Vix

    27.95
    -0.94 (-3.25%)
     
  • GBP/USD

    1.3992
    +0.0070 (+0.50%)
     
  • USD/JPY

    106.6400
    +0.1380 (+0.13%)
     
  • BTC-USD

    46,626.51
    +98.27 (+0.21%)
     
  • CMC Crypto 200

    931.73
    -1.41 (-0.15%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    29,621.26
    +655.25 (+2.26%)
     

Insiders Roundup: Texas Instruments, Homolody Medicines

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
GuruFocus.com
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The GuruFocus All-in-One Screener can be used to find insider trades from a specific period of time or for a certain range of values. For these stock picks, I went under the Insiders tab and changed the settings for All Insider Buying to "$200,000+," the duration to "January 2019" and All Insider Sales to "$200,000+."


According to these filters, the following are this week's most significant trades from company insiders.

Northern Oil & Gas

10% owner Robert B. Rowling bought 3.36 million shares of Northern Oil & Gas Inc. (NOG) for an average price of $1.67 per share on Jan.30.

The company, which operates in the oil and gas industry, has a market cap of $697.96 million and an enterprise value of $1.84 billion. It has institutional ownership of 64.62% and insider ownership of 8.86%.

9f3f984e7b68f0e291ff8ce2195ecc46.png
9f3f984e7b68f0e291ff8ce2195ecc46.png

Over the past 12 months, the stock has declined 32.28%. As of Friday, it was trading 41.50% below its 52-week high and 22.42% above its 52-week low.

Trinity Industries

Bradon B. Boze bought 147,109 shares of Trinity Industries Inc. (TRN) for an average price of $20.85 per share on Jan.29.

The company, which provides products and services to the energy and construction sectors, has a market cap of $2.58 billion and an enterprise value of $7.51 billion. It has institutional ownership of 99.54% and insider ownership of 4%.

a0dc5bd9ee8cc0e9b5dfcfa56ed483ef.png
a0dc5bd9ee8cc0e9b5dfcfa56ed483ef.png

Over the past 12 months, the stock has declined 10.16%. As of Friday, it was trading 21.14% below its 52-week high and 31% above its 52-week low.

vTv Therapeutics

Ronald O. Perelman, 10% owner of vTv Therapeutics Inc. (VTVT), bought 1.25 million shares for an average price of $1.60 per share on Jan. 28.

The company, which develops orally administered small molecule drug candidates for the treatment of neurological disorders, has a market cap of $153.37 billion, an insider ownership of 0.21% and an institutional ownership of 1.82%.

1842f20295208cf463ab5c7f19758292.png
1842f20295208cf463ab5c7f19758292.png

Over the past 12 months, the stock has fallen 18.10%. As of Friday, shares were trading 24.19% below the 52-week high and 91.06% above the 52-week low.

CBA Florida

Cryo Cell International Inc. sold one million shares of CBA Florida Inc. (CBAI) for an average price of 1 cent per share on Jan. 29.

The company, which provides private cord blood and cord tissue stem cell services, has a market cap of $10.18 million and insider ownership of 4.28%.

96581ff234529f784372e4c818c85244.png
96581ff234529f784372e4c818c85244.png

Over the past 12 months, the shares price was stable, and as of Friday, it was trading 20% below its 52-week high and 31.15% above its 52-week low.

Adaptive Biotechnologies

10% owners Viking Global Performance LLC and Viking Global Investors LP sold a combined 9.82 million shares of Adaptive Biotechnologies Corp. (ADPT) for an average price of $24.98 per share on Jan. 28.

The petroleum refiner has a market cap of $3.86 billion, institutional ownership of 71.97% and insider ownership of 4.69%.

4c2e6f0a88b0a8934bd53295c4cd3984.png
4c2e6f0a88b0a8934bd53295c4cd3984.png

Over the past 12 months, the stock declined 23%. As of Friday, it was trading 7.69% below its 52-week high and 22.98% above its 52-week low.

Texas Instruments

Texas Instruments Inc. (TXN)'s chairman and president, Richard K. Templeton, sold 405,000 shares for an average price of $128.74 per share on Jan.28.

The company, which manufactures semiconductors, has a market cap of $116.96 billion and an enterprise value of $117.38 billion. It has insider ownership of 0.48% and institutional ownership of 99.61%.

3a3a8c2944033b6c3353175522a11f70.png
3a3a8c2944033b6c3353175522a11f70.png

Over the past 12 months, the stock has risen 24.64%. As of Friday, shares were trading 7.52% below the 52-week high and 25.28% above the 52-week low.

Homology Medicines

Homology Medicines Inc. (FIXX)' James E. Flynn sold 639,506 shares for an average price of $15.69 per share on Jan.28.

The genetic medicines company has a market cap of $674.61 million, insider ownership of 1.11% and institutional ownership of 99.42%.

65dee16d72d9796b1fd0e6dbfa2c7e01.png
65dee16d72d9796b1fd0e6dbfa2c7e01.png

Over the past 12 months, the stock has fallen 24.42%. As of Friday, shares were trading 51.82% below the 52-week high and 38.64% above the 52-week low.

Disclosure: I do not own any stocks mentioned.

Read more here:



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.